Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Donations From Healthy Probands for the Study of the Adaptive Immune Response to COVID-19 Vaccination (AICOVI)

NCT04826770 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.

NCT NCT04826770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04826770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Donations From Healthy Probands for the Study of the Adaptive Immune Response to COVID-19 Vaccination (AICOVI)
Lead sponsor
University Medicine Greifswald
Phase
Observational
Overall status
Unknown status
Start date
January 6, 2021
Completion date
December 31, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 vaccination